From LL-PLS paper ---- " These findings support the optimization of FcRn interactions in mAb therapies designed for administration during pregnancy."
Most foundationally significant, publication to date.
Now this, makes me say a huge, direct BP partnership, could very possibly be in the works.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-